Concepedia
Statistics
Publications
9
Citations
473
H-Index
Active since
2007
Affiliations
Institute of Cancer Research(Current)
Adaptimmune (United Kingdom)
Cancer Research UK
University of Michigan
Victoria E. Anderson is an author at Institute of Cancer Research specializing in life sciences, oncology, and immunology.
Publications per year
2007–2023
CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors
Victoria E. Anderson, Michael I. Walton, Paul D. Eve et al. · Cancer Research · 2011 · 112 citations · Full text
Life Sciences, Cancer Biology, Molecular Biology +15
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
Joseph P. Sanderson, Darragh Crowley, Guy E. Wiedermann et al. · OncoImmunology · 2019 · 96 citations · Full text
Life Sciences, Immunology, Oncology +17
Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2
Stephen T. Hilton, Sébastien Naud, John Caldwell et al. · Bioorganic & Medicinal Chemistry · 2009 · 57 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +14
Tuning T‐Cell Receptor Affinity to Optimize Clinical Risk‐Benefit When Targeting Alpha‐Fetoprotein–Positive Liver Cancer
Roslin Y. Docta, Tiago Ferronha, Joseph P. Sanderson et al. · Hepatology · 2018 · 53 citations · Full text
Medicine, Immunology, Oncology +17
Structure-Based Design of Potent and Selective 2-(Quinazolin-2-yl)phenol Inhibitors of Checkpoint Kinase 2
John Caldwell, E. Jane Welsh, C. Matijssen et al. · Journal of Medicinal Chemistry · 2010 · 48 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
1–5 of 9